Skip to content


  • Add this article to your LinkedIn page
  • Add this article to your Twitter feed
  • Add this article to your Facebook page
  • Email this article
  • View or print a PDF of this page
  • Share further
  • Add this article to your Pinterest board
  • Add this article to your Google page
  • Share this article on Reddit
  • Share this article on StumbleUpon
  • Bookmark this page

AstraZeneca: Automating high-throughput inhaler testing

AstraZeneca's existing analytical test automation could not be efficiently upgraded or replicated to meet the future capacity requirements for product testing, so a new system was needed.

PA Consulting Group was initially asked to prepare the User Requirements Specification (URS) for the new system. As part of this task, PA conducted over 50 interviews with analytical chemists in AstraZeneca who were to be the future users of the system. 

Having agreed the URS, AstraZeneca asked PA to develop the full system.

At PA's Global Innovation and Technology Centre in Cambridge, UK, we used our in-house facilities to develop prototypes, including control software, for the key modules of the new system.

The new machines matched up to the specification, generating test data four times faster than the previous systems.

Automating high-throughput inhaler testing for @AstraZeneca #pharma #health via @PA_Consulting

Contact the life sciences team